NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

失眠藥物治療的全球市場:按治療進行的市場調查(非處方助眠藥和處方助眠藥),展望(-2025年),COVID-19的累積影響

Insomnia Pharmacological Treatment Market Research Report by Treatment (Over-the-Counter Sleep Aids and Prescription Sleep Aids) - Global Forecast to 2025 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品編碼 973187
出版日期 內容資訊 英文 181 Pages
商品交期: 最快1-2個工作天內
價格
失眠藥物治療的全球市場:按治療進行的市場調查(非處方助眠藥和處方助眠藥),展望(-2025年),COVID-19的累積影響 Insomnia Pharmacological Treatment Market Research Report by Treatment (Over-the-Counter Sleep Aids and Prescription Sleep Aids) - Global Forecast to 2025 - Cumulative Impact of COVID-19
出版日期: 2021年02月04日內容資訊: 英文 181 Pages
簡介

失眠藥物治療的市場規模預計將從2019年的7,148.13百萬美元增長到5.67%的年均增長率(CAGR),到2025年底達到9,952.73百萬美元。

市場細分和覆蓋率

該研究報告對失眠的藥物治療進行了分類,預測了利潤並分析了以下每個子市場的趨勢。

  • 治療在子市場中,市場分為非處方睡眠助劑和處方睡眠助劑。通過抗組胺藥,褪黑激素和纈草根進一步對非處方睡眠助劑進行分類和調查。規定的睡眠助劑被分類和研究為苯二氮卓類,褪黑激素受體拮抗劑,非苯二氮卓類和油性毒素拮抗劑。
  • 按地區將其分類並調查了美洲,亞太地區,歐洲和中東/非洲。美洲地區正在阿根廷,巴西,加拿大,墨西哥和美國進行調查。在澳大利亞,中國,印度,印度尼西亞,日本,馬來西亞,菲律賓,韓國和泰國對亞太地區進行了調查。歐洲是法國,德國,西班牙,意大利,荷蘭,俄羅斯和英國,而中東和非洲是卡塔爾,沙特阿拉伯,南非和阿拉伯聯合酋長國。

企業可用性概況

該調查由EEbb Therapeutics、Eisai Co.、Ltd.、Meda Consumer Healthcare, Inc、Merck & Co., Inc.、Mylan NV、Paratek Pharmaceuticals, Inc.、 Pernix Therapeutics、 Pfizer Inc.、 Purdue Pharmaceuticals L.P.、 Sanofi S.A.、 Sumitomo Dainippon Pharma Co., Ltd.、 Takeda Pharmaceuticals Company Ltd.、れプヂVanda Pharmaceuticals.都在深入探索全球市場領先廠商最近的重大發展和創新概況。

FPNV定位矩陣

FPNV定位矩陣可幫助公司製定更好的決策,並通過業務戰略(業務增長,行業覆蓋範圍,財務可行性,渠道支持)和產品滿意度來瞭解競爭格局。根據(成本性能,易用性,產品功能和客戶支持)對我們市場中的供應商進行評估和分類。

競爭戰略窗口(競爭戰略窗口)

競爭戰略窗口從市場,應用和區域角度分析了競爭格局。這有助於供應商定義能力和機會之間的協調或適應,以實現未來的增長前景。在預測期內,供應商將採用持續的併購策略,區域擴展,研發和新產品實施策略,以最佳或有利地適應進一步的業務擴展和增長。

COVID-19的累積影響

預計COVID-19將在預測期內對行業增長產生長期影響,因為這是無與倫比的全球公共衛生突發事件,幾乎影響了每個行業。我們正在進行的研究擴大了研究框架,以確保它包括潛在的COVID-19問題和潛在的未來路徑。這項研究提供了對COVID-19的見解,同時考慮了不斷變化的消費者行為和需求,購買模式,供應鏈重新路由,當前市場勢力動態以及政府的關鍵干預措施。更新後的調查提供了見解,分析,估計和預測,其中考慮了COVID-19對市場的影響。

該調查提供了有關以下準則的見解:

  • 1.市場滲透率:主要參與者提供的有關市場的全面信息
  • 2.市場開發:有利可圖的新興市場的詳細信息和市場分析
  • 3.市場多元化:有關新產品發佈,欠發達地區,最新發展和投資的更多信息
  • 4.競爭評估和情報:全面評估主要公司的市場份額,戰略,產品和製造能力
  • 5.產品開發和創新:對未來技術,研發活動和新產品開發的智能見解

該調查回答了以下問題

  • 1. 失眠藥物治療的全球市場規模和預測是什麼?
  • 2. 在預測期內,構成市場的COVID-19有哪些障礙和影響?
  • 3. 在預測期內,您將投資哪些產品,細分,應用或領域?
  • 4. 什麼是市場機會的競爭戰略窗口?
  • 5. 什麼是市場技術趨勢和監管框架?
  • 6. 您認為適合進入市場的方式和戰略舉措是什麼?

本報告調查了失眠藥物治療的全球市場,概述了市場,分析了市場增長和障礙,市場機會,市場規模趨勢以及按治療和地區,競爭情況做出的預測,它提供系統信息,例如主要公司的概況。

目錄

第1章序言

  • 調查目的
  • 市場細分和覆蓋範圍
  • 調查對像年度
  • 貨幣和價格
  • 語言
  • 利益相關者

第2章調查方法

  • 調查過程
    • 定義:調查目的
    • 決策:調查設計
    • 準備:測量設備
    • 集合:數據源
    • 分析:數據解釋
    • 配方:數據驗證
    • 發佈:調查報告
    • 重複:更新報告
  • 進行調查
    • 開始:調查過程
    • 計劃:創建調查計劃
    • 執行:進行調查
    • 驗證:發現和分析
    • 出版物:調查報告
  • 調查結果

第3章執行摘要

  • 簡介
  • 市場前景
  • 治療前景
  • 區域展望
  • 競爭對手展望

第4章市場概述

  • 簡介

第5章市場動態

  • 簡介
  • 促進因素
    • 壓力增加和身體殘疾
    • 成人慢性失眠的患病率
    • 增強患者對失眠的認識並增加就診
  • 抑製器
    • 藥物相關的副作用
  • 市場機會
    • 新產品開發
    • 新藥在發展中地區的滲透率提高
  • 挑戰
    • 在某些患者中失眠的個人水平污名

第6章市場洞察

  • 波特五力分析
    • 新進入者的威脅
    • 替代威脅
    • 客戶的議價能力
    • 供應商的談判能力
    • 行業競爭
  • COVID-19的累積效果
  • 客戶端定制

第7章按治療

  • 簡介
  • 非處方睡眠幫助
    • 抗組胺藥
    • 褪黑激素
    • 纈草根
  • 處方助眠藥
    • 苯二氮卓
    • 褪黑激素受體拮抗劑
    • 非苯二氮卓
    • Orexin拮抗劑

第8章美洲

  • 簡介
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區

  • 簡介
  • 澳大利亞
  • 中國
  • 印度
  • 印度尼西亞
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第10章歐洲,中東/非洲

  • 簡介
  • 法國
  • 德國
  • 意大利
  • 荷蘭
  • 卡塔爾
  • 俄羅斯
  • 沙特阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合酋長國
  • 英國

第11章競爭情況

  • FPNV定位矩陣
    • 象限
    • 經營策略
    • 產品滿意度
  • 市場排名分析
  • 市場佔有率分析
  • 競爭情景
    • 併購
    • 協議,合作和夥伴關係
    • 推出和增強新產品
    • 投融資
    • 獎項,表彰,擴展

第12章企業可用性簡介

  • Ebb Therapeutics
  • Eisai Co., Ltd.
  • Meda Consumer Healthcare, Inc
  • Merck & Co., Inc.
  • Mylan N.V.
  • Paratek Pharmaceuticals, Inc.
  • Pernix Therapeutics
  • Pfizer Inc.
  • Purdue Pharmaceuticals L.P.
  • Sanofi S.A.
  • Sumitomo Dainippon Pharma Co., Ltd.
  • Takeda Pharmaceuticals Company Ltd.
  • Vanda Pharmaceuticals

第13章附錄

  • 討論指南
目錄
Product Code: MRR-E792FFF

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

1. The Global Insomnia Pharmacological Treatment Market is expected to grow from USD 7,530.46 Million in 2020 to USD 9,863.52 Million by the end of 2025.

2. The Global Insomnia Pharmacological Treatment Market is expected to grow from EUR 6,602.85 Million in 2020 to EUR 8,648.52 Million by the end of 2025.

3. The Global Insomnia Pharmacological Treatment Market is expected to grow from GBP 5,869.95 Million in 2020 to GBP 7,688.55 Million by the end of 2025.

4. The Global Insomnia Pharmacological Treatment Market is expected to grow from JPY 803,691.64 Million in 2020 to JPY 1,052,687.61 Million by the end of 2025.

5. The Global Insomnia Pharmacological Treatment Market is expected to grow from AUD 10,935.23 Million in 2020 to AUD 14,323.14 Million by the end of 2025.

Market Segmentation & Coverage:

This research report categorizes the Insomnia Pharmacological Treatment to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Treatment, the Insomnia Pharmacological Treatment Market studied across Over-the-Counter Sleep Aids and Prescription Sleep Aids. The Over-the-Counter Sleep Aids further studied across Antihistamines, Melatonin, and Valerian Roots. The Prescription Sleep Aids further studied across Benzodiazepines, Melatonin Receptor Antagonists, Non-benzodiazepines, and Orexin Antagonists.

"The Asia-Pacific is projected to witness the highest growth during the forecast period"

Based on Geography, the Insomnia Pharmacological Treatment Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded the largest size in the Insomnia Pharmacological Treatment Market in 2020. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.

Company Usability Profiles:

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Insomnia Pharmacological Treatment Market including Aa Pharma Inc, Actavis Totowa LLC, Altimed Pharma Inc., Amneal Pharmaceuticals NY LLC, Direct_Rx, Ebb Therapeutics, Eisai Co., Ltd., Foxland Pharmaceuticals, Inc., Fresenius Kabi USA, LLC, Hospira, Inc., Ingenus Pharmaceuticals, LLC, Meda Consumer Healthcare, Inc, MEDA Pharmaceuticals, MedPointe Pharmaceuticals, Merck & Co., Inc., Micro Labs Limited, Mylan N.V., Paratek Pharmaceuticals, Inc., Pernix Therapeutics, Pfizer Inc., Pro Doc Limitee, Purdue Pharmaceuticals L.P., Remedy Repack, Sanofi S.A., Sivem Pharmaceuticals Ulc, Sumitomo Dainippon Pharma Co., Ltd., Takeda Pharmaceuticals Company Ltd., TriVue Pharmaceuticals, Inc., Vanda Pharmaceuticals, and Winthrop U.S..

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

360iResearch™ FPNV Positioning Matrix:

The 360iResearch™ FPNV Positioning Matrix evaluates and categorizes the vendors in the Insomnia Pharmacological Treatment Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

360iResearch™ Competitive Strategic Window:

The 360iResearch™ Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch™ Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Insomnia Pharmacological Treatment Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Insomnia Pharmacological Treatment Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Insomnia Pharmacological Treatment Market?

4. What is the competitive strategic window for opportunities in the Global Insomnia Pharmacological Treatment Market?

5. What are the technology trends and regulatory frameworks in the Global Insomnia Pharmacological Treatment Market?

6. What are the modes and strategic moves considered suitable for entering the Global Insomnia Pharmacological Treatment Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Stakeholders

2. Research Methodology

  • 2.1. Research Process
    • 2.1.1. Define: Research Objective
    • 2.1.2. Determine: Research Design
    • 2.1.3. Prepare: Research Instrument
    • 2.1.4. Collect: Data Source
    • 2.1.5. Analyze: Data Interpretation
    • 2.1.6. Formulate: Data Verification
    • 2.1.7. Publish: Research Report
    • 2.1.8. Repeat: Report Update
  • 2.2. Research Execution
    • 2.2.1. Initiation: Research Process
    • 2.2.2. Planning: Develop Research Plan
    • 2.2.3. Execution: Conduct Research
    • 2.2.4. Verification: Finding & Analysis
    • 2.2.5. Publication: Research Report
  • 2.3. Research Outcome

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Treatment Outlook
  • 3.4. Geography Outlook
  • 3.5. Competitor Outlook

4. Market Overview

  • 4.1. Introduction
  • 4.2. Cumulative Impact of COVID-19

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing stress level and physical disorders
      • 5.1.1.2. Prevalence of chronic insomnia in adult patients
      • 5.1.1.3. Rising awareness among patient and increasing visits to doctor regarding to insomnia
    • 5.1.2. Restraints
      • 5.1.2.1. Side effects associated with drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of novel products
      • 5.1.3.2. Increase in penetration of new pharmaceuticals in developing areas
    • 5.1.4. Challenges
      • 5.1.4.1. Individual level stigma about insomnia in some patients
  • 5.2. Porters Five Forces Analysis
    • 5.2.1. Threat of New Entrants
    • 5.2.2. Threat of Substitutes
    • 5.2.3. Bargaining Power of Customers
    • 5.2.4. Bargaining Power of Suppliers
    • 5.2.5. Industry Rivalry

6. Global Insomnia Pharmacological Treatment Market, By Treatment

  • 6.1. Introduction
  • 6.2. Over-the-Counter Sleep Aids
    • 6.2.1. Antihistamines
    • 6.2.2. Melatonin
    • 6.2.3. Valerian Roots
  • 6.3. Prescription Sleep Aids
    • 6.3.1. Benzodiazepines
    • 6.3.2. Melatonin Receptor Antagonists
    • 6.3.3. Non-benzodiazepines
      • 6.3.3.1. Eszopiclone
      • 6.3.3.2. Zaleplon
      • 6.3.3.3. Zolpidem
    • 6.3.4. Orexin Antagonists

7. Americas Insomnia Pharmacological Treatment Market

  • 7.1. Introduction
  • 7.2. Argentina
  • 7.3. Brazil
  • 7.4. Canada
  • 7.5. Mexico
  • 7.6. United States

8. Asia-Pacific Insomnia Pharmacological Treatment Market

  • 8.1. Introduction
  • 8.2. Australia
  • 8.3. China
  • 8.4. India
  • 8.5. Indonesia
  • 8.6. Japan
  • 8.7. Malaysia
  • 8.8. Philippines
  • 8.9. South Korea
  • 8.10. Thailand

9. Europe, Middle East & Africa Insomnia Pharmacological Treatment Market

  • 9.1. Introduction
  • 9.2. France
  • 9.3. Germany
  • 9.4. Italy
  • 9.5. Netherlands
  • 9.6. Qatar
  • 9.7. Russia
  • 9.8. Saudi Arabia
  • 9.9. South Africa
  • 9.10. Spain
  • 9.11. United Arab Emirates
  • 9.12. United Kingdom

10. Competitive Landscape

  • 10.1. FPNV Positioning Matrix
    • 10.1.1. Quadrants
    • 10.1.2. Business Strategy
    • 10.1.3. Product Satisfaction
  • 10.2. Market Ranking Analysis
  • 10.3. Market Share Analysis
  • 10.4. Competitor SWOT Analysis
  • 10.5. Competitive Scenario
    • 10.5.1. Merger & Acquisition
    • 10.5.2. Agreement, Collaboration, & Partnership
    • 10.5.3. New Product Launch & Enhancement
    • 10.5.4. Investment & Funding
    • 10.5.5. Award, Recognition, & Expansion

11. Company Usability Profiles

  • 11.1. Aa Pharma Inc
  • 11.2. Actavis Totowa LLC
  • 11.3. Altimed Pharma Inc.
  • 11.4. Amneal Pharmaceuticals NY LLC
  • 11.5. Direct_Rx
  • 11.6. Ebb Therapeutics
  • 11.7. Eisai Co., Ltd.
  • 11.8. Foxland Pharmaceuticals, Inc.
  • 11.9. Fresenius Kabi USA, LLC
  • 11.10. Hospira, Inc.
  • 11.11. Ingenus Pharmaceuticals, LLC
  • 11.12. Meda Consumer Healthcare, Inc
  • 11.13. MEDA Pharmaceuticals
  • 11.14. MedPointe Pharmaceuticals
  • 11.15. Merck & Co., Inc.
  • 11.16. Micro Labs Limited
  • 11.17. Mylan N.V.
  • 11.18. Paratek Pharmaceuticals, Inc.
  • 11.19. Pernix Therapeutics
  • 11.20. Pfizer Inc.
  • 11.21. Pro Doc Limitee
  • 11.22. Purdue Pharmaceuticals L.P.
  • 11.23. Remedy Repack
  • 11.24. Sanofi S.A.
  • 11.25. Sivem Pharmaceuticals Ulc
  • 11.26. Sumitomo Dainippon Pharma Co., Ltd.
  • 11.27. Takeda Pharmaceuticals Company Ltd.
  • 11.28. TriVue Pharmaceuticals, Inc.
  • 11.29. Vanda Pharmaceuticals
  • 11.30. Winthrop U.S.

12. Appendix

  • 12.1. Discussion Guide
  • 12.2. License & Pricing

List of Figures

  • FIGURE 1. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: RESEARCH PROCESS
  • FIGURE 2. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: RESEARCH EXECUTION
  • FIGURE 3. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, 2020 VS 2025 (USD MILLION)
  • FIGURE 4. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 6. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, 2018-2025 (USD MILLION)
  • FIGURE 7. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 8. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 10. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: MARKET DYNAMICS
  • FIGURE 11. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 12. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2020 VS 2025 (%)
  • FIGURE 13. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2020 VS 2025 (USD MILLION)
  • FIGURE 14. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2025
  • FIGURE 15. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2020 VS 2025 (USD MILLION)
  • FIGURE 16. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY ANTIHISTAMINES, 2020 VS 2025 (USD MILLION)
  • FIGURE 17. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY MELATONIN, 2020 VS 2025 (USD MILLION)
  • FIGURE 18. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY VALERIAN ROOTS, 2020 VS 2025 (USD MILLION)
  • FIGURE 19. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2020 VS 2025 (USD MILLION)
  • FIGURE 20. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY BENZODIAZEPINES, 2020 VS 2025 (USD MILLION)
  • FIGURE 21. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY MELATONIN RECEPTOR ANTAGONISTS, 2020 VS 2025 (USD MILLION)
  • FIGURE 22. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2020 VS 2025 (USD MILLION)
  • FIGURE 23. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY ESZOPICLONE, 2020 VS 2025 (USD MILLION)
  • FIGURE 24. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY ZALEPLON, 2020 VS 2025 (USD MILLION)
  • FIGURE 25. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY ZOLPIDEM, 2020 VS 2025 (USD MILLION)
  • FIGURE 26. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OREXIN ANTAGONISTS, 2020 VS 2025 (USD MILLION)
  • FIGURE 27. AMERICAS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 28. AMERICAS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 30. ARGENTINA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 31. BRAZIL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 32. CANADA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 33. MEXICO INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 34. UNITED STATES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 35. ASIA-PACIFIC INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 36. ASIA-PACIFIC INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 37. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 38. AUSTRALIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 39. CHINA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 40. INDIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 41. INDONESIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 42. JAPAN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 43. MALAYSIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 44. PHILIPPINES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 45. SOUTH KOREA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 46. THAILAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 47. EUROPE, MIDDLE EAST & AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 48. EUROPE, MIDDLE EAST & AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 49. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 50. FRANCE INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 51. GERMANY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 52. ITALY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 53. NETHERLANDS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 54. QATAR INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 55. RUSSIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 56. SAUDI ARABIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 57. SOUTH AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 58. SPAIN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 59. UNITED ARAB EMIRATES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 60. UNITED KINGDOM INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 61. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: 360IRESEARCH™ FPNV POSITIONING MATRIX
  • FIGURE 62. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: 360IRESEARCH™ MARKET SHARE ANALYSIS
  • FIGURE 63. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: COMPETITOR SWOT ANALYSIS
  • FIGURE 64. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET, BY TYPE

List of Tables

  • TABLE 1. CURRENCY CONVERSION RATES
  • TABLE 2. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 3. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY ANTIHISTAMINES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY MELATONIN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY VALERIAN ROOTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY BENZODIAZEPINES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY MELATONIN RECEPTOR ANTAGONISTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY ESZOPICLONE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY ZALEPLON, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY ZOLPIDEM, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OREXIN ANTAGONISTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. AMERICAS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. AMERICAS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. ARGENTINA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. BRAZIL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. CANADA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. MEXICO INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. UNITED STATES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. ASIA-PACIFIC INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. ASIA-PACIFIC INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. AUSTRALIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. CHINA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. INDIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. INDONESIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. JAPAN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. MALAYSIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. PHILIPPINES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. SOUTH KOREA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. THAILAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. EUROPE, MIDDLE EAST & AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. EUROPE, MIDDLE EAST & AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. FRANCE INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. GERMANY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. ITALY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. NETHERLANDS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. QATAR INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. RUSSIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. SAUDI ARABIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. SOUTH AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. SPAIN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. UNITED ARAB EMIRATES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. UNITED KINGDOM INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: SCORES
  • TABLE 49. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: BUSINESS STRATEGY
  • TABLE 50. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: PRODUCT SATISFACTION
  • TABLE 51. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: RANKING
  • TABLE 52. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: MERGER & ACQUISITION
  • TABLE 53. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 54. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 55. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: INVESTMENT & FUNDING
  • TABLE 56. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 57. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: LICENSE & PRICING